|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 278.35 INR | -0.89% |
|
-5.39% | +33.73% |
| 05-20 | Viyash Scientific Limited, Q4 2026 Earnings Call, May 20, 2026 | |
| 05-19 | Viyash Scientific March-quarter consol net profit 521.1 million rupees | RE |
| Market Cap | 121B 1.27B 1.11B 1.03B 949M 1.8B 1.83B 12.28B 4.82B 59.85B 4.78B 4.68B 206B | P/E 2026 |
45.7x | P/E 2027 * | 31.8x |
|---|---|---|---|---|---|
| Enterprise Value | 125B 1.31B 1.14B 1.05B 973M 1.85B 1.88B 12.58B 4.94B 61.34B 4.9B 4.8B 211B | EV / Sales 2026 |
2.4x | EV / Sales 2027 * | 3.12x |
| Free-Float |
32.09% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Viyash Scientific Limited
| 1 day | -0.89% | ||
| 1 week | -5.39% | ||
| Current month | +0.60% | ||
| 1 month | +10.50% | ||
| 3 months | +33.15% | ||
| 6 months | +40.47% | ||
| Current year | +33.73% |
| 1 week | 268.2 |  | 297.9 |
| 1 month | 242.55 | | 297.9 |
| Current year | 178.4 | | 297.9 |
| 1 year | 166.2 | | 297.9 |
| 3 years | 86.03 | | 297.9 |
| 5 years | 61.8 | | 319 |
| 10 years | 42.45 | | 336.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 2025-12-15 | |
Ramakant Singani
DFI | Director of Finance/CFO | - | 2025-12-31 |
| Chief Tech/Sci/R&D Officer | - | 2026-02-04 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 78 | - | |
| Director/Board Member | 66 | 2020-08-24 | |
| Director/Board Member | - | 2025-12-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.89% | -5.39% | +48.10% | +218.59% | 1.27B | |
| -2.33% | -2.09% | +50.33% | +162.29% | 1,060B | |
| -0.82% | -2.30% | +62.97% | +61.11% | 619B | |
| -0.73% | -4.98% | +27.22% | +84.46% | 438B | |
| +0.33% | -1.17% | +27.98% | +26.90% | 333B | |
| -0.02% | -2.85% | +25.27% | +44.88% | 282B | |
| -3.89% | -11.22% | +20.78% | +26.07% | 267B | |
| +0.66% | -1.42% | -29.26% | -39.30% | 218B | |
| -0.06% | -2.88% | +20.98% | +61.70% | 196B | |
| -3.72% | -1.10% | +13.35% | +71.53% | 161B | |
| Average | -0.89% | -3.46% | +26.77% | +71.82% | 357.52B | |
| Weighted average by Cap. | -0.56% | -2.96% | +35.29% | +81.32% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 33.72B 354M 309M 285M 263M 500M 508M 3.41B 1.34B 16.61B 1.33B 1.3B 57.11B | 38.99B 409M 358M 330M 305M 578M 588M 3.94B 1.55B 19.21B 1.54B 1.5B 66.04B |
| Net income | 2.18B 22.86M 19.99M 18.44M 17.03M 32.32M 32.86M 220M 86.53M 1.07B 85.82M 83.96M 3.69B | 3.83B 40.18M 35.15M 32.42M 29.94M 56.81M 57.77M 387M 152M 1.89B 151M 148M 6.49B |
| Net Debt | 3.02B 31.65M 27.69M 25.54M 23.59M 44.76M 45.51M 305M 120M 1.49B 119M 116M 5.11B | - |
Employees
1,244
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-10 | ₹278.35 | -0.89% | 47,034 |
| 26-07-09 | ₹280.85 | +3.63% | 79,832 |
| 26-07-08 | ₹271.00 | -2.87% | 112,804 |
| 26-07-07 | ₹279.00 | -3.59% | 79,383 |
| 26-07-06 | ₹289.40 | -1.63% | 102,742 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
278.35INR
Average target price
312.67INR
Spread / Average Target
+12.33%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIYASH Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
